Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: WESTAT, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-03-07 to 2028-07-31
Current total value of award: $1125154
Description: THE CONTRACTOR SHALL COORDINATE, MAINTAIN AND MANAGE NICHD PARTICIPATING SITES FOR IMPAACT 2041: PHASE I/II STUDY OF THE PHARMACOKINETICS AND SAFETY OF GLECAPREVIR/PIBRENTASVIR INITIATED IN PREGNANCY IN PEOPLE WITH HEPATITIS C WITH AND WITHOUT HIV.